CMS pitches expanded coverage of PET scans for Alzheimer’s disease
(By Rylee Wilson for Becker’s Hospital Review) CMS is proposing broader coverage of PET scans for patients with Alzheimer’s disease,
Read More
Alzheimer’s/Dementia
Advanced dementia patients often need a BRO
(Source – news.va.gov) Alzheimer’s. Dementia. These diagnoses rip the chord of safety and certainty in patients, families and caregivers at
Read MoreHearing aids may slow mental decline in those at higher risk of dementia, study finds
(By Lizzy Lawrence for STAT) Doctors have long suspected that hearing loss in older adults hastens dementia, the cognitive decline
Read MoreAn experimental Alzheimer’s drug outperforms one just approved by the FDA
(By Jon Hamilton for NPR) Patients in the early stages of Alzheimer’s may soon have a new option to stave
Read MoreResearchers turn to CRISPR to unlock one of the trickiest diseases to treat: Alzheimer’s
(By Andrew Joseph for STAT) When the genome-editing tool CRISPR is thought of as a potential medicine, the targets that
Read MoreWill the new Alzheimer’s drug put pressure on Medicare premiums?
The FDA approved the drug Leqembi, and Medicare will cover the new expensive new drug that promises the slowing the
Read MoreLeqembi could cost Medicare up to $17.8B
(By Rylee Wilson for Becker’s Hospital Review) Leqembi, the newly-approved drug that can slow the progression of Alzhemier’s disease, will
Read MoreStatement: Broader Medicare Coverage of Leqembi Available Following FDA Traditional Approval
(Source – www.cms.gov/newsroom) Broader Medicare coverage is now available for Biogen and Eisai’s Leqembi (the brand name for lecanemab) following
Read MoreWhy the Next Big Hope for Alzheimer’s Might Not Help Most Black Patients
(By Arthur Allen for KFF Health News) This week the FDA is expected to approve what many scientists and doctors
Read MoreAfter ICU discharge, Alzheimer’s patients’ risk of dying doubles: Study
(By Bari Faye Dean for Becker’s Hospital Review) Older adults with Alzheimer’s disease and related dementia are twice as likely
Read More